Dow Down 0.02% Nasdaq Up 0.07%

TrovaGene, Inc. (TROV)

-NasdaqCM
4.69 0.04(0.85%) Nov 25, 3:59PM EST
Prev Close:4.73
Open:4.71
Bid:1.00 x 100
Ask:5.08 x 300
1y Target Est:9.00
Beta:1.42
Next Earnings Date:N/A
Day's Range:4.66 - 4.83
52wk Range:2.97 - 7.10
Volume:20,241
Avg Vol (3m):143,186
Market Cap:88.65M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TROV

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):329.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.73
Quarterly EPS Est (Dec-14) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback